Product Information
ATORVASTATIN 20 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0356 per EA under NDC 16729004517. Its NADAC has been published 325 times since Aug 29, 2018.
FDA first approved this application on Mar 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729004517
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207687FDA Approved
3/30/2018
TE Code
AB
On Market Since
8/6/2018
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 20 MG TABLET has been published 325 times since Aug 29, 2018, and over the history we have for it it has declined 59.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0356 per EA |
|---|---|
| All-time high | $0.0889 (Jul 10, 2019) |
| All-time low | $0.0301 (Jul 17, 2024) |
| Median price | $0.0551 |
| Average price | $0.0567 |
| Largest weekly change | +32.4% (Aug 21, 2024) |
| Weeks tracked | 325 |
| Tracking since | Aug 29, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-12.4%
5Y
-35.5%
All
-59.3%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0356 per EA (NDC 16729004517), effective Nov 13, 2024.
How has the price of ATORVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 59.3%. It has been tracked across 325 weekly CMS publications since Aug 29, 2018.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?
Since Aug 29, 2018, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0301 (Jul 17, 2024) to a high of $0.0889 (Jul 10, 2019), with a median of $0.0551 per EA.
Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 20 MG TABLET, is $0.0276 per EA — about 23% below ATORVASTATIN 20 MG TABLET.
Who manufactures ATORVASTATIN 20 MG TABLET?
ATORVASTATIN 20 MG TABLET (NDC 16729004517) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.